oncogene

Imagine your cells are tiny construction workers building and maintaining your body. Oncogenes are like faulty blueprints that tell those workers to build too much, too quickly, leading to uncontrolled growth, which is a key sign of cancer. They usually come from normal genes called proto-oncogenes that become mutated or overactive. Think of it like a car's accelerator getting stuck, constantly pushing for more speed (cell division) with no proper brakes.

Oncogenes are key players in how cancers develop, and understanding them helps doctors and scientists create targeted treatments. For example, changes in the HER2 gene are found in some breast cancers and can be treated with specific drugs. Scientists study these genes to understand what drives cancer cells and how to stop them.

Our bodies are built from trillions of cells, each following instructions encoded in our DNA. Within that DNA are proto-oncogenes—normal genes responsible for regulating cell growth and division. They're like the gas pedal in a car, carefully controlling how fast things go. But sometimes, these proto-oncogenes can become altered, mutated, or overexpressed, turning into what we call oncogenes.

An oncogene is a gene that can help cause cancer when it becomes activated or overly active in the wrong way. This does not mean that cancer will always develop, but it does raise the risk by pushing cells to grow and divide when they should not. These genes can override the usual signals that tell cells when to slow down or stop. This runaway process can lead to tumors and, ultimately, cancer.

There are several ways a proto-oncogene can become an oncogene: through mutations (changes in the DNA sequence), gene amplification (making too many copies of the gene), or chromosomal rearrangements (moving genes to new locations where they're overly active).

Different types of cancers often involve different oncogenes. Some well-known examples include MYC, RAS, and ERBB2 (also known as HER2). Researchers are actively studying these oncogenes to understand exactly how they contribute to cancer development. This knowledge is vital for creating targeted therapies—drugs that specifically block the activity of oncogenes, effectively slowing or stopping cancer growth.

So, while proto-oncogenes are essential for normal cell function, their corrupted counterparts—oncogenes—are powerful drivers of cancer, and understanding them is a critical step in the global fight against this disease.